James David Clark
Known title: SVP, Cont & Chief Acct OfficerCIK: 0001757584
Associated companies
Transaction History
| CVS | ▼ Sell | Tax Withholding | 454 | $41K | 6/26/2026 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 3,262 | $236K | 4/1/2026 | View on chart |
| CVS | ▲ Buy | Grant | 11,138 | $800K | 3/31/2026 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 220 | $17K | 12/1/2025 | View on chart |
| CVS | ▲ Buy | Grant | 14,710 | $1000K | 4/1/2025 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 2,266 | $154K | 4/1/2025 | View on chart |
| CVS | ▲ Buy | Option Exercise | 7,513 | $467K | 3/5/2025 | View on chart |
| CVS | ▼ Sell | Open Market | 7,513 | $498K | 3/5/2025 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 86 | $5K | 11/30/2024 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 1,112 | $88K | 4/1/2024 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 1,892 | $151K | 4/1/2024 | View on chart |
| CVS | ▲ Buy | Grant | 10,683 | $850K | 4/1/2024 | View on chart |
| CVS | ▲ Buy | Grant | 2,452 | $0 | 2/12/2024 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 122 | $8K | 12/14/2023 | View on chart |
| CVS | ▼ Sell | Open Market | 2,631 | $197K | 8/3/2023 | View on chart |
| CVS | ▼ Sell | Open Market | 23,128 | $1.7M | 8/3/2023 | View on chart |
| CVS | ▲ Buy | Grant | 2,186 | $162K | 4/1/2023 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 1,471 | $109K | 4/1/2023 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 179 | $15K | 2/28/2023 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 153 | $16K | 12/1/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 3,897 | $394K | 4/1/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 2,740 | $277K | 4/1/2022 | View on chart |
| CVS | ▲ Buy | Grant | 3,214 | $325K | 4/1/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 253 | $26K | 2/28/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 183 | $19K | 2/28/2022 | View on chart |
| CVS | ▲ Buy | Grant | 8,595 | $0 | 2/21/2022 | View on chart |
| CVS | ▲ Buy | Option Exercise | 6,059 | $620K | 1/28/2022 | View on chart |
| CVS | ▼ Sell | Open Market | 6,059 | $660K | 1/28/2022 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 68 | $6K | 12/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status
CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.